Stay updated on Brentuximab Vedotin Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.

Latest updates to the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now indicates recruitment is closed for the study; additional help/navigation links were added and the Intervention/Treatment heading formatting was adjusted.SummaryDifference0.2%

- Check20 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, signaling a new version of the page. This appears to be a meta update indicating a page refresh or minor changes rather than core content changes.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a newer version of the study record. This appears to be a metadata update rather than a substantive change to the study details.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page revision label was updated from v3.5.2 to v3.5.3, signaling a maintenance update to the page's documentation rather than a modification to the study details.SummaryDifference0.0%

- Check71 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2. No changes to study content or configuration are visible.SummaryDifference0.0%

- Check99 days agoChange DetectedFive new Virginia sites were added (Williamsburg, Newport News, Hampton, Chesapeake, Virginia Beach), bringing the total locations to 93. The study record was updated to revision v3.5.0 with completion dates noted.SummaryDifference0.6%

Stay in the know with updates to Brentuximab Vedotin Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin Plus Pembrolizumab Clinical Trial page.